Literature DB >> 28976337

Incidental Tc-99m Methylene Diphosphonate Uptake in an Active Thyroid Nodule.

Derya Çayır1, Mine Araz1, Şafak Akın2, Melia Karaköse2, Erman Çakal2.   

Abstract

Tc-99m-methylene diphosphonate (MDP) whole body scintigraphy is the method of choice for detection of metastatic bone diseases. It is primarily used to help diagnose various bone-related conditions such as primary or metastatic cancer of the bone, location of bone inflammation, and fractures that may not be visible on traditional X-ray images, as well as detection of bone damage due to infections and other conditions. In addition, bone scanning is often used for the follow-up or evaluation of response to treatment in some malignancies like prostate and breast cancers. Pathologies of other systems can also be incidentally detected on whole body bone scan. Herein we present an interesting image of an active thyroid nodule that showed Tc-99m MDP uptake in a prostate cancer patient.

Entities:  

Keywords:  Tc-99m medronate radionuclide imaging.; Thyroid nodule

Year:  2017        PMID: 28976337      PMCID: PMC5643942          DOI: 10.4274/mirt.37167

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther


  6 in total

1.  Myocardial, pulmonary, diaphragmatic, gastric, splenic, and renal uptake of Tc-99m MDP in a patient with persistent, severe hypercalcemia.

Authors:  A K Padhy; P G Gopinath; A C Amini
Journal:  Clin Nucl Med       Date:  1990-09       Impact factor: 7.794

Review 2.  Skeletal scintigraphy in breast cancer management.

Authors:  R Bares
Journal:  Q J Nucl Med       Date:  1998-03

Review 3.  18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.

Authors:  Werner Langsteger; Alireza Rezaee; Christian Pirich; Mohsen Beheshti
Journal:  Semin Nucl Med       Date:  2016-09-13       Impact factor: 4.446

4.  A new complex of 99mTc for skeletal imaging.

Authors:  G Subramanian; J G McAfee
Journal:  Radiology       Date:  1971-04       Impact factor: 11.105

5.  Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.

Authors:  G Subramanian; J G McAfee; R J Blair; F A Kallfelz; F D Thomas
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

6.  Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.

Authors:  P J Peller; V B Ho; M J Kransdorf
Journal:  Radiographics       Date:  1993-07       Impact factor: 5.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.